Apparently, yes! There is a newly discovered strain of plant other than cannabis that contains cannabidiol (CBD). And some people are hoping that this could lead to CBD finally becoming legal anywhere.
What is this plant?
There is a type of hop plant that produces CBD. This is an obscure species that is native to southern China, in the areas bordering India. It is typical to the Yunnan province, so the taxonomical name of this specific variety of hop plant is humulus yunnanensis.
Humulus yunnanensis is one of three species of the humulus genus. This is different from humulus lupulus, which is a species whose female flowers are used to make beer.
Discovering CBD in pot plant
Dr. Bomi Joseph recently discovered that there is a strain of humulus yunnanensis that naturally produces CBD. That is because this variety of hop plant, which can be found in the Silk Road region of northern India, cross-pollinates with wild cannabis plants that grow nearby.
Joseph subsequently crossbred these hop plants to create a chemovar* that produces about 18 percent of CBD. He called this variety the kriya brand humulus.
Joseph holds a patent for the kriya brand humulus, as well as any modification of other humulus plants to produce CBD.
Joseph runs Peak Health Foundation, a holistic medicine center in in San Francisco, California. Peak Health extracts CBD oil from the kriya brand humulus and calls this ImmunAG.
Peak Health created Real Scientific Humulus Oil, its brand of CBD oil derived from the kriya brand humulus plant. And because it is not from cannabis, the oil is legal in the United States.
It is said that the CBD oil from the kriya brand humulus is sweet because it is technically a whole-plant extract. This means that it has all the original terpenes that is thought to augment and affect the cannabis experience.
* A chemovar is a particular species of plants whose chemical composition varies from the average due to different environmental growing conditions.
What could this mean, legally speaking?
The hop-based CBD would certainly have a global ramification for the CBD market, according to Dr. Stuart Titus, CEO of Medical Marijuana Inc.
This, he added, would help change the dialogue for many parents who have epileptic children, as well as for various other world markets where cannabis is considered a part of the United Nations single convention treaty on narcotics.
Many believe that hop-based CBD might be the loophole in the Controlled Substances Act that the market needs. So until the world learns to accept cannabis, hop-based CBD may just be the next big thing in CBD.